Cash Flow Champs & Cautions: Interface vs Etsy & Ten X Genomics

Interface, a flooring leader, is generating impressive free cash flow margins, making it a company to watch. Etsy and ten x Genomics, despite strong cash flows, face challenges. Etsys buyer numbers and sales are declining, while ten x Genomics struggles with weak revenue growth and negative returns on capital. Investors are cautious, with Etsy trading at 11.6 times forward EV over EBITDA and ten x Genomics at 4.6 times forward price-to-sales. Interface, however, is thriving with surging earnings, revenue gains, and improving free cash margins, making it an attractive option for reinvestment or buybacks. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b135137a016cb89b